Vault-13

SAMSARA BIOCAPITAL, LLC

PALO ALTO, CA · CIK 1744967 · 13F filing filed 2024-08-14

SEC-registered investment adviser since 2018 · limited liability company

As an employer

US visa salary filings

Job titleFilingsMedianRange
Senior AssociatePalo Alto, CA 2 $187,500 $175,000 – $200,000

Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Samsara BioCapital, LLC.

$477.8m reported value -26.1% vs Q1 2024
40positions
73.6%in top 10
3 new 3 added 3 reduced 2 sold out vs Q1 2024

Holdings, Q2 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CARGO THERAPEUTICS INC COM COM 4,415,689 $72.5m15.17% 15.17% AddedShares held: Q3 2023 0, Q4 2023 4.1m, Q1 2024 4.1m, Q2 2024 4.4m +294.0k +294,000 7.1%
2 MINERALYS THERAPEUTICS INC COM MLYS MLYS 5,074,916 $59.4m12.43% 12.43% UnchangedShares held: Q3 2023 4.5m, Q4 2023 4.5m, Q1 2024 5.1m, Q2 2024 5.1m
3 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 6,788,609 $56.5m11.84% 11.84% UnchangedShares held: Q3 2023 4.6m, Q4 2023 6.8m, Q1 2024 6.8m, Q2 2024 6.8m
4 NEUROGENE INC COM NGNE NGNE 1,267,790 $46.1m9.66% 9.66% UnchangedShares held: Q3 2023 0, Q4 2023 1.3m, Q1 2024 1.3m, Q2 2024 1.3m
5 ARCELLX INC COMMON STOCK ACLX ACLX 453,641 $25.0m5.24% 5.24% UnchangedShares held: Q3 2023 613.9k, Q4 2023 460.4k, Q1 2024 453.6k, Q2 2024 453.6k
6 CLIMB BIO INC COM CLYM CLYM 3,261,393 $23.2m4.85% 4.85% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 3.3m
7 NKARTA INC COM NKTX NKTX 3,768,035 $22.3m4.66% 4.66% UnchangedShares held: Q3 2023 2.9m, Q4 2023 2.9m, Q1 2024 3.8m, Q2 2024 3.8m
8 LENZ THERAPEUTICS INC COM LENZ LENZ 1,208,473 $20.9m4.37% 4.37% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 1.2m, Q2 2024 1.2m
9 AVADEL PHARMACEUTICALS PLC COM SHS AVDL AVDL 967,527 $13.6m2.85% 2.85% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 967.5k
10 JASPER THERAPEUTICS INC COM NEW JSPR JSPR 525,000 $11.9m2.49% 2.49% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 525.0k, Q2 2024 525.0k
11 HILLEVAX INC COM COM 799,274 $11.6m2.42% 2.42% UnchangedShares held: Q3 2023 799.3k, Q4 2023 799.3k, Q1 2024 799.3k, Q2 2024 799.3k
12 ABIVAX SA SPONSORED ADS ABVX ABVX 850,000 $11.2m2.35% 2.35% UnchangedShares held: Q3 2023 0, Q4 2023 850.0k, Q1 2024 850.0k, Q2 2024 850.0k
13 ACELYRIN INC COM COM 2,523,022 $11.1m2.33% 2.33% UnchangedShares held: Q3 2023 2.4m, Q4 2023 2.5m, Q1 2024 2.5m, Q2 2024 2.5m
14 CONTINEUM THERAPEUTICS INC CL A CTNM CTNM 588,817 $10.4m2.17% 2.17% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 588.8k
15 SYROS PHARMACEUTICALS INC COM NEW SYRS SYRS 1,786,427 $9.2m1.93% 1.93% UnchangedShares held: Q3 2023 881.5k, Q4 2023 1.8m, Q1 2024 1.8m, Q2 2024 1.8m
16 ZYMEWORKS INC COM ZYME ZYME 1,000,000 $8.5m1.78% 1.78% ReducedShares held: Q3 2023 1.5m, Q4 2023 1.5m, Q1 2024 1.5m, Q2 2024 1.0m -458.9k -458,875 -31.4%
17 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 172,647 $7.1m1.48% 1.48% UnchangedShares held: Q3 2023 345.3k, Q4 2023 172.6k, Q1 2024 172.6k, Q2 2024 172.6k
18 INOZYME PHARMA INC COM COM 1,562,500 $7.0m1.46% 1.46% UnchangedShares held: Q3 2023 1.6m, Q4 2023 1.6m, Q1 2024 1.6m, Q2 2024 1.6m
19 SUTRO BIOPHARMA INC COM COM 2,196,814 $6.4m1.35% 1.35% AddedShares held: Q3 2023 1.7m, Q4 2023 1.7m, Q1 2024 1.7m, Q2 2024 2.2m +521.2k +521,235 31.1%
20 GOSSAMER BIO INC COM GOSS GOSS 6,130,268 $5.5m1.16% 1.16% UnchangedShares held: Q3 2023 6.1m, Q4 2023 6.1m, Q1 2024 6.1m, Q2 2024 6.1m
21 TANGO THERAPEUTICS INC COM TNGX TNGX 630,000 $5.4m1.13% 1.13% UnchangedShares held: Q3 2023 630.0k, Q4 2023 630.0k, Q1 2024 630.0k, Q2 2024 630.0k
22 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 347,500 $5.0m1.05% 1.05% UnchangedShares held: Q3 2023 347.5k, Q4 2023 347.5k, Q1 2024 347.5k, Q2 2024 347.5k
23 LEAP THERAPEUTICS INC COM NEW CYPH CYPH 2,442,352 $4.8m1.00% 1.00% AddedShares held: Q3 2023 602.2k, Q4 2023 669.3k, Q1 2024 669.3k, Q2 2024 2.4m +1.8m +1,773,049 264.9%
24 IO BIOTECH INC COM IOBTQ IOBTQ 3,640,015 $4.3m0.89% 0.89% UnchangedShares held: Q3 2023 3.6m, Q4 2023 3.6m, Q1 2024 3.6m, Q2 2024 3.6m
25 VTV THERAPEUTICS INC CL A NEW VTVT VTVT 206,784 $3.7m0.76% 0.76% UnchangedShares held: Q3 2023 0, Q4 2023 40.9k, Q1 2024 206.8k, Q2 2024 206.8k
26 PRIME MEDICINE INC COM PRME PRME 540,304 $2.8m0.58% 0.58% UnchangedShares held: Q3 2023 470.3k, Q4 2023 470.3k, Q1 2024 540.3k, Q2 2024 540.3k
27 DAY ONE BIOPHARMACEUTICALS I COM COM 196,425 $2.7m0.57% 0.57% UnchangedShares held: Q3 2023 196.4k, Q4 2023 196.4k, Q1 2024 196.4k, Q2 2024 196.4k
28 IMMATICS N.V SHS IMTX IMTX 198,000 $2.3m0.48% 0.48% ReducedShares held: Q3 2023 396.0k, Q4 2023 396.0k, Q1 2024 396.0k, Q2 2024 198.0k -198.0k -198,000 -50.0%
29 JANUX THERAPEUTICS INC COM JANX JANX 45,052 $1.9m0.39% 0.39% ReducedShares held: Q3 2023 360.4k, Q4 2023 360.4k, Q1 2024 180.2k, Q2 2024 45.1k -135.2k -135,155 -75.0%
30 TERNS PHARMACEUTICALS INC COM COM 202,348 $1.4m0.29% 0.29% UnchangedShares held: Q3 2023 202.3k, Q4 2023 202.3k, Q1 2024 202.3k, Q2 2024 202.3k
31 IGM BIOSCIENCES INC COM IGMS IGMS 154,664 $1.1m0.22% 0.22% UnchangedShares held: Q3 2023 154.7k, Q4 2023 154.7k, Q1 2024 154.7k, Q2 2024 154.7k
32 BOLT BIOTHERAPEUTICS INC COM COM 1,049,153 $786.9k0.16% 0.16% UnchangedShares held: Q3 2023 1.0m, Q4 2023 1.0m, Q1 2024 1.0m, Q2 2024 1.0m
33 LYRA THERAPEUTICS INC COM LYRA LYRA 2,780,261 $769.3k0.16% 0.16% UnchangedShares held: Q3 2023 2.8m, Q4 2023 2.8m, Q1 2024 2.8m, Q2 2024 2.8m
34 ACLARIS THERAPEUTICS INC COM ACRS ACRS 696,171 $765.8k0.16% 0.16% UnchangedShares held: Q3 2023 696.2k, Q4 2023 696.2k, Q1 2024 696.2k, Q2 2024 696.2k
35 VIRACTA THERAPEUTICS INC COM SNSS SNSS 689,709 $375.0k0.08% 0.08% UnchangedShares held: Q3 2023 689.7k, Q4 2023 689.7k, Q1 2024 689.7k, Q2 2024 689.7k
36 ALLAKOS INC COM ALLKG ALLKG 172,089 $172.1k0.04% 0.04% UnchangedShares held: Q3 2023 172.1k, Q4 2023 172.1k, Q1 2024 172.1k, Q2 2024 172.1k
37 KRONOS BIO INC COM KRON KRON 78,131 $96.9k0.02% 0.02% UnchangedShares held: Q3 2023 78.1k, Q4 2023 78.1k, Q1 2024 78.1k, Q2 2024 78.1k
38 ALLOVIR INC COM COM 82,336 $59.6k0.01% 0.01% UnchangedShares held: Q3 2023 82.3k, Q4 2023 82.3k, Q1 2024 82.3k, Q2 2024 82.3k
39 NUVATION BIO INC *W EXP 07/07/202 NUVB.WS NUVB.WS 133,333 $21.3k0.00% 0.00% UnchangedShares held: Q3 2023 133.3k, Q4 2023 133.3k, Q1 2024 133.3k, Q2 2024 133.3k
40 SURROZEN INC *W EXP 08/01/203 *W EXP 08/01/203 99,999 $1.7k0.00% 0.00% UnchangedShares held: Q3 2023 100.0k, Q4 2023 100.0k, Q1 2024 100.0k, Q2 2024 100.0k

Sold out since Q1 2024

SecurityTickerShares held beforeValue then
AVADEL PHARMACEUTICALS PLC 967,527 $16.3m967.5k shares
ADVERUM BIOTECHNOLOGIES INC ADVM ADVM 291,666 $4.1m291.7k shares